The Novel Coronavirus 2019 epidemic and kidneys

Saraladevi Naicker, Chih-Wei Yang, Shang-Jyh Hwang, Bi-Cheng Liu, Jiang-Hua Chen, Vivekanand Jha, Saraladevi Naicker, Chih-Wei Yang, Shang-Jyh Hwang, Bi-Cheng Liu, Jiang-Hua Chen, Vivekanand Jha

No abstract available

Keywords: acute kidney injury; hemodialysis.

References

    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA.10.1001/jama.2020.1585. Accessed March 2, 2020.
    1. World Health Organization Coronavirus disease (COVID-2019) situation reports. Available at:
    1. World Health Organization Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) Available at:
    1. World Health Organization Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available at:
    1. World Health Organization Middle East respiratory syndrome coronavirus (MERS-CoV). November 2019. Available at:
    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497–506.
    1. Center for Disease Control and Prevention Frequently asked questions and answers: Coronavirus Disease-2019 (COVID-19) and children. Available at:
    1. Ling L., Taisheng L. The National Health Commission of PRC Guideline for diagnosis and treatment of novel coronavirus disease (version 6) Natl Med J China. 2020;100:E001.
    1. World Health Organization Specimen referral for 2019nCoV - operational details of referral laboratories. Available at:
    1. Normile D. Singapore claims first use of antibody test to track coronavirus infections. Available at:
    1. Chen N., Zhou M., Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
    1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China [e-pub ahead of print]. N Engl J Med.10.1056/NEJMoa2002032. Accessed March 2, 2020.
    1. Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients [e-pub ahead of print]. medRxiv 2020.02.18.20023242. 10.1101/2020.02.18.20023242. Accessed March 2, 2020.
    1. Li Z., Wu M., Guo J. Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv 2020.02.08.20021212
    1. Li W., Moore M.J., Vasilieva N. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454.
    1. Raj V.S., Mou H., Smits S.L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251–254.
    1. Peiri J.S.M., Chu C.M., Cheng V.C.C. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772.
    1. Ding Y., He L., Zhang Q. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203:622–630.
    1. The team of Zhong Nanshan responded that the isolation of SARS-CoV-2 from urine remind us to pay more attention to the cleaning of individuals and families. Guangzhou Daily. Published February 22, 2020
    1. Expert Team of Chinese Society of Nephrology Expert consensus on diagnosis and treatment of 2019 novel coronavirus (2019 - nCoV) infection with acute kidney injury. Chin J Nephrol. 2020;3 doi: 10.3760/cma.j.cn441217-20200222-00035.
    1. Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14:72–73.
    1. Chu K.H., Tsang W.K., Tang C.S. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67:698–705.
    1. Arabi Y.M., Arifi A.A., Balkhy H.H. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160:389–397.
    1. Ghani R.A., Zainudin S., Ctkong N. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology (Carlton) 2006;11:386–393.
    1. Chen R.C., Tang X.P., Tan S.Y. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441–1452.
    1. Arabi Y.M., Mandourah Y., Al-Hameed F. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med. 2018;197:757–767.
    1. Stockman L.J., Bellamy R., Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343.
    1. Russell C.D., Millar J.E., Baillie J.K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473–475.
    1. Park B.K., Maharjan S., Lee S.I. Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex. BMB Rep. 2019;52:397–402.
    1. Ma Y., Diao B., Lv X. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China. Available at:
    1. Expert Team of Chinese Medical Association Nephrology Branch Recommendations for prevention and control of novel coronavirus infection in blood purification center (room) from Chinese Medical Association Nephrology Branch. Chin J Nephrol. 2020;36:82–84.
    1. Hwang S.-J. Guideline for dialysis facilities during COVID-19 outbreak. Taiwan Society of Nephrology. Available at:

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren